166 related articles for article (PubMed ID: 18082966)
1. Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents.
Chou J; Luo Y; Kuo CC; Powers K; Shen H; Harvey BK; Hoffer BJ; Wang Y
Neuroscience; 2008 Jan; 151(1):92-103. PubMed ID: 18082966
[TBL] [Abstract][Full Text] [Related]
2. 9-Cis retinoic acid protects against methamphetamine-induced neurotoxicity in nigrostriatal dopamine neurons.
Reiner DJ; Yu SJ; Shen H; He Y; Bae E; Wang Y
Neurotox Res; 2014 Apr; 25(3):248-61. PubMed ID: 23884514
[TBL] [Abstract][Full Text] [Related]
3. Nigrostriatal alterations in bone morphogenetic protein receptor II dominant negative mice.
Chou J; Harvey BK; Ebendal T; Hoffer B; Wang Y
Acta Neurochir Suppl; 2008; 101():93-8. PubMed ID: 18642641
[TBL] [Abstract][Full Text] [Related]
4. Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration.
Harvey BK; Chou J; Shen H; Hoffer BJ; Wang Y
Neurotoxicology; 2009 May; 30(3):436-44. PubMed ID: 19442829
[TBL] [Abstract][Full Text] [Related]
5. Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ.
Shin EJ; Duong CX; Nguyen XT; Li Z; Bing G; Bach JH; Park DH; Nakayama K; Ali SF; Kanthasamy AG; Cadet JL; Nabeshima T; Kim HC
Behav Brain Res; 2012 Jun; 232(1):98-113. PubMed ID: 22512859
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell lines.
Nam Y; Wie MB; Shin EJ; Nguyen TT; Nah SY; Ko SK; Jeong JH; Jang CG; Kim HC
J Appl Toxicol; 2015 Aug; 35(8):927-44. PubMed ID: 25523949
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease.
Harvey BK; Mark A; Chou J; Chen GJ; Hoffer BJ; Wang Y
Brain Res; 2004 Oct; 1022(1-2):88-95. PubMed ID: 15353217
[TBL] [Abstract][Full Text] [Related]
8. Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease.
Yin LH; Shen H; Diaz-Ruiz O; Bäckman CM; Bae E; Yu SJ; Wang Y
BMC Neurosci; 2012 Oct; 13():120. PubMed ID: 23040108
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic Neuron-Specific Deletion of p53 Gene Attenuates Methamphetamine Neurotoxicity.
Lu T; Kim PP; Greig NH; Luo Y
Neurotox Res; 2017 Aug; 32(2):218-230. PubMed ID: 28342134
[TBL] [Abstract][Full Text] [Related]
10. Pifithrin-Alpha Reduces Methamphetamine Neurotoxicity in Cultured Dopaminergic Neurons.
Chen YH; Bae E; Chen H; Yu SJ; Harvey BK; Greig NH; Wang Y
Neurotox Res; 2019 Aug; 36(2):347-356. PubMed ID: 31069753
[TBL] [Abstract][Full Text] [Related]
11. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
[TBL] [Abstract][Full Text] [Related]
12. Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb.
Deng X; Ladenheim B; Jayanthi S; Cadet JL
Biol Psychiatry; 2007 Jun; 61(11):1235-43. PubMed ID: 17161385
[TBL] [Abstract][Full Text] [Related]
13. Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK.
Dang DK; Shin EJ; Nam Y; Ryoo S; Jeong JH; Jang CG; Nabeshima T; Hong JS; Kim HC
J Neuroinflammation; 2016 Jan; 13():12. PubMed ID: 26780950
[TBL] [Abstract][Full Text] [Related]
14. BMP7 reduces synergistic injury induced by methamphetamine and ischemia in mouse brain.
Shen H; Luo Y; Kuo CC; Wang Y
Neurosci Lett; 2008 Sep; 442(1):15-8. PubMed ID: 18598737
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.
Liu B; Traini R; Killinger B; Schneider B; Moszczynska A
Exp Neurol; 2013 Sep; 247():359-72. PubMed ID: 23313192
[TBL] [Abstract][Full Text] [Related]
16. Methamphetamine alters reference gene expression in nigra and striatum of adult rat brain.
He Y; Yu S; Bae E; Shen H; Wang Y
Neurotoxicology; 2013 Dec; 39():138-45. PubMed ID: 24042092
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Theodore S; Cass WA; Maragos WF
Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease.
Yasuhara T; Shingo T; Kobayashi K; Takeuchi A; Yano A; Muraoka K; Matsui T; Miyoshi Y; Hamada H; Date I
Eur J Neurosci; 2004 Mar; 19(6):1494-504. PubMed ID: 15066146
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.
Ares-Santos S; Granado N; Espadas I; Martinez-Murillo R; Moratalla R
Neuropsychopharmacology; 2014 Apr; 39(5):1066-80. PubMed ID: 24169803
[TBL] [Abstract][Full Text] [Related]
20. Neonatal methamphetamine in the rat: evidence for gender-specific differences upon tyrosine hydroxylase enzyme in the dopaminergic nigrostriatal system.
Gomes-da-Silva J; Perez-Rosado A; de Miguel R ; Fernandez-Ruiz J; Silva MC; Tavares MA
Ann N Y Acad Sci; 2000 Sep; 914():431-8. PubMed ID: 11085342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
